KA
Ketan Agrawal
About Ketan Agrawal
Data last updated:
Ketan Agrawal is a Director at Caventis Pharma Private Limited (since 2018) and Director at Rhizoid Healthcare Private Limited (since 2021). The companies operate in Pharma and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹4.96 Cr; the largest is Caventis Pharma Private Limited at ₹4.88 Cr (FY 2024). Earlier, Ketan Agrawal was a Director at Great Choice Industries Private Limited (from 2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Oct 2018 | 2012 | ₹4.88 Cr (FY 2024) | Active | |
| Director | 23 Jun 2021 | 2021 | ₹8.2 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Nov 2013 | 2013 | ₹19,842 (FY 2017) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ketan Agrawal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kushal Agrawal | 03520935 | Caventis Pharma Private Limited , Rhizoid Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ketan Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ketan Agrawal
Ketan Agrawal currently holds 2 directorships: Caventis Pharma Private Limited (Director, since 22 Oct 2018, revenue ₹4.88 Cr (FY 2024)); Rhizoid Healthcare Private Limited (Director, since 23 Jun 2021, revenue ₹8.2 Lakh (FY 2024)).
Ketan Agrawal was first appointed on 13 Nov 2013 as Director at Great Choice Industries Private Limited. The most recent appointment on record is 23 Jun 2021 at Rhizoid Healthcare Private Limited.
The 2 current companies of Ketan Agrawal that report revenue have a combined latest revenue of ₹4.96 Cr: Caventis Pharma Private Limited ₹4.88 Cr (FY 2024); Rhizoid Healthcare Private Limited ₹8.2 Lakh (FY 2024).
Ketan Agrawal held 1 earlier board appointment: Great Choice Industries Private Limited (Director, from 13 Nov 2013).
The current boards of Ketan Agrawal's companies include Kushal Agrawal (Caventis Pharma Private Limited).